Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #26736
advertisement
Aihara M
52
Showing records 1 to 25 |
Display all abstracts from
Aihara M
126900
Relationships between distance from the fovea to the disc and macular retinal layer thickness differ between normal and glaucomatous eyes
Higashide T
Scientific reports
2025; 15: 11554
126508
Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma
Suzuki H
Japanese Journal of Ophthalmology
2025; 69: 287-295
125620
Real-Time In Vivo Monitoring of Eye Drop Concentration Using Boron-Doped Diamond Microelectrodes and Its Relevance to Drug Efficacy
Ogawa R
ACS sensors
2025; 0:
125095
Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Sit AJ
Survey of Ophthalmology
2025; 70: 918-929
126696
Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY Study
Aihara M
Journal of Glaucoma
2025; 34: 310-316
125699
Management of Intraocular Pressure Elevation After Commercially Available Cultivated Oral Mucosal Epithelial Cell Transplantation for Limbal Stem Cell Deficiency
Goto H
Cureus
2025; 17: e81341
125547
Visual Field of Eyes with Peripapillary Intrachoroidal Cavitation and Its Association with Deep Optic Nerve Head Structural Changes
Akiyama K
Ophthalmology. Glaucoma
2025; 0:
126696
Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY Study
Lu F
Journal of Glaucoma
2025; 34: 310-316
125699
Management of Intraocular Pressure Elevation After Commercially Available Cultivated Oral Mucosal Epithelial Cell Transplantation for Limbal Stem Cell Deficiency
Ono T
Cureus
2025; 17: e81341
125547
Visual Field of Eyes with Peripapillary Intrachoroidal Cavitation and Its Association with Deep Optic Nerve Head Structural Changes
Aoki S
Ophthalmology. Glaucoma
2025; 0:
126900
Relationships between distance from the fovea to the disc and macular retinal layer thickness differ between normal and glaucomatous eyes
Udagawa S
Scientific reports
2025; 15: 11554
126508
Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma
Sakata R
Japanese Journal of Ophthalmology
2025; 69: 287-295
125620
Real-Time In Vivo Monitoring of Eye Drop Concentration Using Boron-Doped Diamond Microelectrodes and Its Relevance to Drug Efficacy
Ogata G
ACS sensors
2025; 0:
125095
Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Aihara M
Survey of Ophthalmology
2025; 70: 918-929
126900
Relationships between distance from the fovea to the disc and macular retinal layer thickness differ between normal and glaucomatous eyes
Araie M
Scientific reports
2025; 15: 11554
126508
Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma
Yamae T
Japanese Journal of Ophthalmology
2025; 69: 287-295
125620
Real-Time In Vivo Monitoring of Eye Drop Concentration Using Boron-Doped Diamond Microelectrodes and Its Relevance to Drug Efficacy
Yamagishi R
ACS sensors
2025; 0:
125095
Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Khawaja AP
Survey of Ophthalmology
2025; 70: 918-929
126696
Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY Study
Ikeda T
Journal of Glaucoma
2025; 34: 310-316
125699
Management of Intraocular Pressure Elevation After Commercially Available Cultivated Oral Mucosal Epithelial Cell Transplantation for Limbal Stem Cell Deficiency
Taketani Y
Cureus
2025; 17: e81341
125547
Visual Field of Eyes with Peripapillary Intrachoroidal Cavitation and Its Association with Deep Optic Nerve Head Structural Changes
Shirato S
Ophthalmology. Glaucoma
2025; 0:
126900
Relationships between distance from the fovea to the disc and macular retinal layer thickness differ between normal and glaucomatous eyes
Saito H
Scientific reports
2025; 15: 11554
126508
Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma
Ishiyama Y
Japanese Journal of Ophthalmology
2025; 69: 287-295
125620
Real-Time In Vivo Monitoring of Eye Drop Concentration Using Boron-Doped Diamond Microelectrodes and Its Relevance to Drug Efficacy
Honjo M
ACS sensors
2025; 0:
125095
Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Lin SC
Survey of Ophthalmology
2025; 70: 918-929
«
1
2
3
»
Issue
25-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept